Core Points - The company held its 11th board meeting on September 17, 2025, where it approved the purchase of bank wealth management products and the convening of the 6th extraordinary shareholders' meeting [1][3]. Group 1: Board Meeting Resolutions - The board approved the purchase of bank wealth management products with a total investment not exceeding RMB 10 billion, aimed at utilizing idle funds effectively [7][10]. - The board also approved the convening of the 6th extraordinary shareholders' meeting scheduled for October 9, 2025 [3][17]. Group 2: Investment Details - The investment will be made in fixed-income non-principal guaranteed floating return wealth management products and structured deposits from banks and their subsidiaries, excluding products from Zhuhai China Resources Bank [9]. - The investment period is from the approval date until October 9, 2026, with individual product terms not exceeding six months [10][11]. Group 3: Approval Process - The investment proposal has been reviewed and approved by the board and will be submitted to the shareholders' meeting for further approval [12]. - The investment does not constitute a related party transaction and complies with relevant laws and regulations [12]. Group 4: Shareholders' Meeting Details - The extraordinary shareholders' meeting will be held on October 9, 2025, with both on-site and online voting options available [18][27]. - Shareholders must register for the meeting between September 28 and September 30, 2025 [23][24].
华润三九医药股份有限公司2025年第十一次董事会会议决议公告